GO Term | Evidence Code | PMID |
---|---|---|
cellular response to luteinizing hormone stimulus | ||
trabecular meshwork development | ||
cellular response to tumor necrosis factor | ||
response to dexamethasone | ||
negative regulation of cell population proliferation |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:539 | ophthalmoplegia | |
DOID:540 | strabismus | |
DOID:5403 | microcystic adenoma | |
DOID:5520 | head and neck squamous cell carcinoma | |
DOID:5614 | eye disease | |
DOID:5672 | large intestine cancer | |
DOID:5675 | cribriform carcinoma | |
DOID:5679 | retinal disease | |
DOID:5723 | optic atrophy | |
DOID:5844 | myocardial infarction |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000486 | Strabismus |
HP:0000501 | Glaucoma |
HP:0000505 | Visual impairment |
HP:0000523 | Subcapsular cataract |
HP:0000525 | Abnormality iris morphology |
HP:0000541 | Retinal detachment |
HP:0000557 | Buphthalmos |
HP:0000572 | Visual loss |
HP:0000587 | Abnormal optic nerve morphology |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103178928 | CALMI16679 | ||
102362765 | LATCH13053 | ||
100150054 | ZFIN:ZDB-GENE-030902-1 | DANRE51342 | |
103036816 | ASTMX12103 | ||
100313516 | ICTPU26558 | ||
113579900 | ELEEL24477 | ||
106576803 | SALSA58343 | ||
106604807 | SALSA67237 | ||
115153034 | SALTR07184 | ||
115193979 | SALTR89651 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024